Reduction of liver stiffness by interferon treatment in the patients with chronic hepatitis C-Reference-Cited by-同舟云学术

Reduction of liver stiffness by interferon treatment in the patients with chronic hepatitis C

Published:2010-04 Issue:4 Volume:40 Page:383-392
ISSN:1386-6346
Container-title:Hepatology Research
language:en
Short-container-title:

Author:

Arima Yuko,Kawabe Naoto,Hashimoto Senju,Harata Masao,Nitta Yoshifumi,Murao Michihito,Nakano Takuji,Shimazaki Hiroaki,Kobayashi Kyoko,Ichino Naohiro,Osakabe Keisuke,Nishikawa Toru,Okumura Akihiko,Ishikawa Tetsuya,Yoshioka Kentaro

Publisher

Wiley

Subject

Infectious Diseases,Hepatology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1872-034X.2009.00618.x/fullpdf

Reference43 articles.

1. Epidemiology of hepatitis C;Alter;Hepatology,1997

2. Hepatitis C;Di Bisceglie;Lancet,1998

3. Hepatitis C: the clinical spectrum of the disease;Marcellin;J Hepatol,1999

4. Meta-analysis of interferon randomized trials in the treatment of viral hepatitis C: effects of dose and duration;Poynard;Hepatology,1996

5. Interferon alfa-2b alone or in combination with ribavirin for the treatment of relapse of chronic hepatitis C. International Hepatitis Interventional Therapy Group;Davis;N Engl J Med,1998

Cited by 57 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Evaluation of liver fibrosis using hepatic extracellular volume fraction by contrast-enhanced computed tomography before and after direct-acting antiviral therapy in patients with chronic hepatitis C infection: comparison with serological liver fibrosis markers;The British Journal of Radiology;2021-11-01

2. Noninvasive Assessment of Hepatitis C Virus Infected Patients Using Vibration-Controlled Transient Elastography;Journal of Clinical Medicine;2021-06-10

3. Diabetes influences liver stiffness in chronic hepatitis patients with and without virological cure: A longitudinal study;CLINICS;2021

4. Elastography After Treatment and During Follow-Up;Elastography of the Liver and Beyond;2021

5. Noninvasive biomarkers predict improvement in liver fibrosis after successful generic DAAs based therapy of chronic hepatitis C in Egypt;Clinical Epidemiology and Global Health;2020-12